Mangoceuticals, Inc. (MGRX) Operating cash flow 2022–2025
Mangoceuticals, Inc. (MGRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.9MFY2025 · since FY2022: -$1.3M → -$5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.9M | -20.3% |
| FY2024 | -$4.9M | +30.5% |
| FY2023 | -$7.0M | -419.7% |
| FY2022 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MGRX financial trends
MGRX RevenueMGRX Net incomeMGRX Net marginMGRX Gross profitMGRX Gross marginMGRX Operating incomeMGRX Operating marginMGRX Free cash flowMGRX Capital expendituresMGRX Return on equityMGRX Stock buybacksMGRX Dividends paidMGRX Total assetsMGRX Total liabilitiesMGRX Shareholders’ equityMGRX overview →